Rising Prevalence Of Arthritis Pain Is Fueling The Market Growth Due To Increasing Aging Population And Musculoskeletal Conditions Is Supporting Development Across The Chronic Pain Treatment Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Chronic Pain Treatment Market During The Forecast Period?

The chronic pain treatment market has experienced robust growth in recent years. This market is projected to expand from $109.05 billion in 2025 to $119.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this growth can be attributed to factors such as opioid usage, musculoskeletal disorders, an aging population, the proliferation of hospital pain clinics, and advancements in post-surgical pain management.

The chronic pain treatment market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $168.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.1%. This expansion during the forecast period is primarily driven by factors such as stricter opioid regulation, the adoption of device-based therapies, the increasing prevalence of chronic diseases, greater integration of mental health services, and the rise of outpatient pain care. Significant trends foreseen for this period include a move towards non-opioid pain treatments, the increasing use of neuromodulation devices, the broader implementation of multidisciplinary pain management approaches, a heightened emphasis on personalized pain care, and the incorporation of psychological support therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Market Drivers Are Helping Shape The Chronic Pain Treatment Market Expansion?

The increasing occurrence of arthritis-related pain is anticipated to drive the expansion of the chronic pain treatment market in the future. Arthritis pain is characterized by discomfort, aches, or tenderness in the joints resulting from inflammation or degeneration associated with arthritis. This growing prevalence of arthritis pain primarily stems from the aging demographic, given that the natural wear and tear on joints intensifies with age, contributing to a higher incidence of arthritis-related conditions. Chronic pain treatment addresses arthritis pain by focusing on reducing inflammation and nerve sensitivity, thereby alleviating discomfort, enhancing joint mobility, and improving the general quality of life for those experiencing ongoing arthritis symptoms. For example, data from July 2024, provided by the Centers for Disease Control and Prevention, a US-based government body, indicated that approximately 21.2% of adults aged 18 and older in the US had received an arthritis diagnosis in 2023. Consequently, the increasing prevalence of arthritis pain is propelling the expansion of the chronic pain treatment market.

How Is The Chronic Pain Treatment Market Distributed Across Key Segments?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

Which Trends Are Influencing The Direction Of The Chronic Pain Treatment Market?

Leading companies active in the chronic pain treatment market are prioritizing the development of innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems, to address the growing demand for advanced non-opioid therapies, superior long-term pain management, and an improved quality of life for patients. These closed-loop SCS systems are implantable, rechargeable neurostimulators that continually sense neural signals and autonomously adjust electrical stimulation in real time, unlike traditional open-loop SCS devices that deliver a fixed, non-responsive output. For example, in April 2024, Medtronic plc, an Ireland-based medical device manufacturer, obtained U.S. Food and Drug Administration (FDA) approval for its Inceptiv Neurostimulation System. This device is a compact, rechargeable implant that utilizes sensing electrodes to observe evoked neural responses and automatically fine-tune stimulation. It supports full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain, engineered to provide more consistent pain relief, better responder outcomes, and enhanced comfort compared to conventional fixed-output SCS systems.

Which Companies Form The Competitive Landscape Of The Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Access The Complete Chronic Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Which Region Contributes The Most To The Chronic Pain Treatment Market?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Chronic Pain Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795